Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial
Phase of Trial: Phase II
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Dronabinol (Primary)
- Indications Sleep apnoea syndrome
- Focus Proof of concept; Registrational; Therapeutic Use
- Acronyms PACE
- 08 Jan 2018 According to a RespireRx Pharmaceuticals media release, data from this trial will be presented at The Biotech Showcase 2018.
- 30 Nov 2017 Results presented in a RespireRx Pharmaceuticals media release.
- 30 Nov 2017 According to a RespireRx Pharmaceuticals media release, results from this trial have been published in the journal SLEEP.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History